Optimizing Busulfan Pharmacokinetic Testing
Click CC to turn on closed captioning.
June 2009
Dr. Snozek provides an overview of pharmacokinetic testing for intravenous dosing of busulfan, an alkylating agent used for bone marrow ablation prior to hematopoietic stem cell transplantation. She discusses the details of specimen collection, assay procedure, and result reporting.
Presenter:
- Christine Snozek, PhD, DABCC, Assistant Professor of Laboratory Medicine and Pathology and Associate Director of the Toxicology and Drug Monitoring Laboratory in the Division of Clinical Biochemistry & Immunology at Mayo Clinic
Print Options
- Before viewing, print the Notes Pages.
- After viewing, obtain a Record of Viewing.
Forward to a Colleague
If you have questions, e-mail


